Credit Suisse’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,568
| Closed | -$271K | – | 3046 |
|
|
2023
Q3 | $271K | Sell |
14,568
-2,036
| -12% | -$37.9K | ﹤0.01% | 2953 |
|
|
2023
Q2 | $431K | Buy |
16,604
+2,862
| +21% | +$74.4K | ﹤0.01% | 2841 |
|
|
2023
Q1 | $395K | Buy |
13,742
+2,993
| +28% | +$86K | ﹤0.01% | 2858 |
|
|
2022
Q4 | $318K | Sell |
10,749
-8,582
| -44% | -$254K | ﹤0.01% | 2988 |
|
|
2022
Q3 | $460K | Buy |
19,331
+66
| +0.3% | +$1.57K | ﹤0.01% | 2818 |
|
|
2022
Q2 | $430K | Sell |
19,265
-909
| -5% | -$20.3K | ﹤0.01% | 2919 |
|
|
2022
Q1 | $507K | Buy |
20,174
+2,641
| +15% | +$66.4K | ﹤0.01% | 2946 |
|
|
2021
Q4 | $628K | Sell |
17,533
-795
| -4% | -$28.5K | ﹤0.01% | 2880 |
|
|
2021
Q3 | $780K | Sell |
18,328
-1,985
| -10% | -$84.5K | ﹤0.01% | 2741 |
|
|
2021
Q2 | $880K | Buy |
20,313
+1,013
| +5% | +$43.9K | ﹤0.01% | 2716 |
|
|
2021
Q1 | $787K | Sell |
19,300
-7,192
| -27% | -$293K | ﹤0.01% | 2701 |
|
|
2020
Q4 | $1.2M | Sell |
26,492
-211
| -0.8% | -$9.56K | ﹤0.01% | 2460 |
|
|
2020
Q3 | $944K | Sell |
26,703
-5,947
| -18% | -$210K | ﹤0.01% | 2305 |
|
|
2020
Q2 | $1.23M | Buy |
32,650
+7,554
| +30% | +$285K | ﹤0.01% | 2191 |
|
|
2020
Q1 | $725K | Sell |
25,096
-962
| -4% | -$27.8K | ﹤0.01% | 2330 |
|
|
2019
Q4 | $1.35M | Buy |
26,058
+13,604
| +109% | +$705K | ﹤0.01% | 2324 |
|
|
2019
Q3 | $685K | Buy |
12,454
+3,425
| +38% | +$188K | ﹤0.01% | 2615 |
|
|
2019
Q2 | $367K | Sell |
9,029
-4,461
| -33% | -$181K | ﹤0.01% | 2949 |
|
|
2019
Q1 | $408K | Buy |
13,490
+562
| +4% | +$17K | ﹤0.01% | 2882 |
|
|
2018
Q4 | $434K | Buy |
12,928
+2,060
| +19% | +$69.2K | ﹤0.01% | 2813 |
|
|
2018
Q3 | $459K | Sell |
10,868
-4,639
| -30% | -$196K | ﹤0.01% | 2885 |
|
|
2018
Q2 | $496K | Sell |
15,507
-258
| -2% | -$8.25K | ﹤0.01% | 2974 |
|
|
2018
Q1 | $783K | Buy |
15,765
+3,321
| +27% | +$165K | ﹤0.01% | 2723 |
|
|
2017
Q4 | $671K | Sell |
12,444
-5,486
| -31% | -$296K | ﹤0.01% | 2784 |
|
|
2017
Q3 | $1.04M | Buy |
17,930
+11,296
| +170% | +$655K | ﹤0.01% | 2614 |
|
|
2017
Q2 | $328K | Sell |
6,634
-8,573
| -56% | -$424K | ﹤0.01% | 3026 |
|
|
2017
Q1 | $660K | Sell |
15,207
-6,108
| -29% | -$265K | ﹤0.01% | 2766 |
|
|
2016
Q4 | $1.04M | Buy |
21,315
+5,695
| +36% | +$279K | ﹤0.01% | 2660 |
|
|
2016
Q3 | $748K | Sell |
15,620
-14,916
| -49% | -$714K | ﹤0.01% | 2861 |
|
|
2016
Q2 | $1.64M | Sell |
30,536
-15,168
| -33% | -$814K | ﹤0.01% | 2245 |
|
|
2016
Q1 | $2.04M | Buy |
45,704
+21,804
| +91% | +$975K | ﹤0.01% | 1953 |
|
|
2015
Q4 | $912K | Buy |
23,900
+9,662
| +68% | +$369K | ﹤0.01% | 2678 |
|
|
2015
Q3 | $454K | Sell |
14,238
-276
| -2% | -$8.8K | ﹤0.01% | 3266 |
|
|
2015
Q2 | $480K | Buy |
14,514
+2,716
| +23% | +$89.8K | ﹤0.01% | 3487 |
|
|
2015
Q1 | $486K | Sell |
11,798
-4,709
| -29% | -$194K | ﹤0.01% | 3291 |
|
|
2014
Q4 | $672K | Sell |
16,507
-7,242
| -30% | -$295K | ﹤0.01% | 3134 |
|
|
2014
Q3 | $870K | Sell |
23,749
-13,655
| -37% | -$500K | ﹤0.01% | 2806 |
|
|
2014
Q2 | $1.73M | Sell |
37,404
-7,538
| -17% | -$349K | ﹤0.01% | 2473 |
|
|
2014
Q1 | $1.85M | Buy |
44,942
+25,182
| +127% | +$1.03M | ﹤0.01% | 2271 |
|
|
2013
Q4 | $754K | Buy |
19,760
+3,716
| +23% | +$142K | ﹤0.01% | 3086 |
|
|
2013
Q3 | $384K | Buy |
16,044
+1,372
| +9% | +$32.8K | ﹤0.01% | 3223 |
|
|
2013
Q2 | $249K | Buy |
+14,672
| New | +$249K | ﹤0.01% | 3350 |
|